Cargando…
New LncRNAs in Chronic Hepatitis C progression: from fibrosis to hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death in the world, and about 80% of the cases are associated with hepatitis B or C. Genetic and epigenetic alterations are accumulated over decades of chronic injury and may affect the functioning of tumor suppressor genes...
Autores principales: | Ferrasi, Adriana Camargo, Fernandez, Geysson Javier, Grotto, Rejane Maria Tommasini, Silva, Giovanni Faria, Goncalves, Joao, Costa, Marina C., Enguita, Francisco J., Pardini, Maria Inês de Moura Campos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303194/ https://www.ncbi.nlm.nih.gov/pubmed/32555359 http://dx.doi.org/10.1038/s41598-020-66881-2 |
Ejemplares similares
-
Human platelet antigen-3 polymorphism as a risk factor for
rheumatological manifestations in hepatitis C
por: Medolago, Natália Bronzatto, et al.
Publicado: (2020) -
Platelets can be a biological compartment for the Hepatitis C
Virus
por: Ariede, Jovita Ramos, et al.
Publicado: (2015) -
Influence of the HIV GWG variant in the HIV infection progression in mono and HCV coinfected patients
por: Hebeler-Barbosa, Flavia, et al.
Publicado: (2019) -
Variability and resistance mutations in the hepatitis C virus NS3 protease in patients not treated with protease inhibitors
por: Zeminian, Luciana Bonome, et al.
Publicado: (2013) -
Transcriptomic Profile of Canine Mammary Ductal Carcinoma
por: Santos, Driéle B., et al.
Publicado: (2023)